Immunitybio Inc (IBRX)

Cash & Short-Term Investments

$357.37M

Quarterly · Period ending: · USD

IBRX logo

IBRX Cash & Short-Term Investments

Latest reported$357.37M
IBRX Quarterly Cash & Short-Term Investments ($59.10M → $357.37M)
High-resolution chart · PNG

IBRX cash & short-term investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Immunitybio Inc Cash & Short-Term Investments — Quarterly (USD)
Period endingCash & Short-Term Investments (USD)
357,371,000
380,879,000
242,818,000
257,813,000
153,658,000
61,591,000
149,809,000
130,367,000
217,979,000
170,495,000
266,462,000
189,796,000
45,954,000
91,268,000
107,184,000
111,057,000
82,938,000
192,332,000
317,116,000
80,372,000
103,928,000
83,273,000
96,061,000
61,663,000
110,623,000
40,215,000
51,652,000
66,057,000
84,052,000
98,549,000
74,149,000
83,308,000
104,944,000
121,789,000
128,152,000
152,267,000
175,505,000
190,970,000
198,921,000
209,256,000
213,763,000
221,759,000
294,218,000
358,616,000
120,437,000
49,854,000
59,104,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.